Prostate Cancer

"As a muso, he was a giant," Anderson said.

"His contribution to music is invaluable and that contribution will live on." Anderson and Wells were the driving force behind Rose Tattoo, who became a local and international success with their blues-based rock in the late 1970s and early 80s.

At the heart of their sound was Wells's well-crafted slide guitar playing, a style that would become his trademark.

back PRINT-FRIENDLY VERSION EMAIL THIS STORY privacy terms © The Australian IN THIS SECTION State funeral for Pro HartToilet humour triumphs in Bald ArchyDone praises Hart as man and artistPro Hart diesConman accessed all areasPro Hart dies, aged 77Young troubadours sing the praises of industry assistanceBrando's sizzling first testPicking among the popGiant of the natural worldRoll up for the showUneasy work an easy pick to winOut of whackIntriguing image mired in confusing allegoryFrench correctionSunny side upOn the reboundHas opera lost the plot?

Archibald awardedAn artist's life with his critic CATCH UP See the top stories from: Yesterday 2 days ago 3 days ago 4 days ago 5 days ago 6 days ago #sidebar { position: absolute; top: 120px; left: 764px; width: 130px; text-align: center; background-color: white; display: block; z-index: 1; } ...

"Radiation oncologists and urologists who use TargetScan report greater treatment success, improved patient comfort and reduced risks of post-treatment side effects, like incontinence and sexual dysfunction." According to Mills, TargetScan represents the first system to address the unmet treatment planning and brachytherapy seed placement needs of radiation oncologists.

Unlike conventional devices, TargetScan provides physicians with a stationary probe to eliminate prostate movement during treatments and reduce procedure times.

The device also offers improved 3-dimensional imaging, with views of both sagittal and transverse planes, to ensure that the brachytherapy radioactive seed implants are accurately placed at physicians' pre-planned targets.

"The partnership with Envisioneering allows our company to advance its mission of providing brachytherapists with the most innovative technologies for improving prostate brachytherapy implants," said Jim Matons, BrachySciences president.

"We are delighted to have signed an exclusive distribution agreement with Envisioneering as we believe TargetScan represents a major step forward in prostate ultrasound technology." Until now, only a select group of physicians have conducted prostate cancer brachytherapy procedures using TargetScan.

The director of clinical research for the Seattle Prost...